HomeInsightsPE

Dr Reddys Laboratories Ltd PE Ratio

Dr Reddys Laboratories Ltd PE Ratio

stocks purchased

₹ 7.8 Cr

Volume Transacted

(Nov 21, 2024)

stocks purchased

64.9 K

Stocks Traded

(Nov 21, 2024)

Last Updated on: Nov 22, 2024

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

PE

18.7

Last updated on: Nov 22, 2024

Key Highlights

  • The P/E Ratio of Dr Reddys Laboratories Ltd is 18.7 as of 22 Nov 9.00 AM .
  • The P/E Ratio of Dr Reddys Laboratories Ltd changed from 23.6 on March 2019 to 18.4 on March 2024 . This represents a CAGR of -4.06% over 6 years.
  • The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1194 as of 21 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Dr Reddys Laboratories Ltd

No data available

Company Fundamentals for Dr Reddys Laboratories Ltd

No data available

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Share Price

₹ 1194.55

-19.40 (-1.60%)

stock direction

Last updated on: Nov 21, 2024

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20241194.55
19 Nov 20241213.95
18 Nov 20241193.35
14 Nov 20241226.05
13 Nov 20241245.7
12 Nov 20241263.1
11 Nov 20241288.2
08 Nov 20241281.85
07 Nov 20241287.15
06 Nov 20241303

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Dr Reddys Laboratories Ltd1899,671
Sun Pharmaceuticals Industries Ltd384,26,518
Divis Laboratories Ltd861,58,636
Cipla Ltd251,18,365
Torrent Pharmaceuticals Ltd601,05,067
Mankind Pharma Ltd481,02,273

Key Valuation Metric of Dr Reddys Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Dr Reddys Laboratories Ltd

No data available

* All values are in %

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories was incorporated in the year 1984 in Hyderabad.

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting...

Read more

2024-08-21 00:00:00

News

Dr Reddy's formulations manufacturing units receives EIR from USFDA

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its form...

Read more

2024-08-12 00:00:00

News

Dr Reddys allots 29,790 equity shares under ESOP

Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ...

Read more

2024-08-07 00:00:00

News

Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA

The inspection has been classified as voluntary action indicated (VAI) and has been closed...

Read more

2024-09-06 00:00:00

News

DRL's Andhra Pradesh facility gets 3 observations from USFDA

According to the exchange filing the United States Food & Drug Administration (USFDA) has ...

Read more

2024-08-24 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Dr Reddys Laboratories Ltd

What is the current PE Ratio of Dr Reddys Laboratories Ltd?

The Current PE Ratio of Dr Reddys Laboratories Ltd is 18.67 as on 22 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Nov 2024.

What was the PE Ratio of Dr Reddys Laboratories Ltd last year?

The PE Ratio of Dr Reddys Laboratories Ltd was 17.08 last year, now the PE ratio is 18.67, showing a year-on-year growth of 9.3%.

What does the PE Ratio of Dr Reddys Laboratories Ltd indicate about its stock?

The PE Ratio of Dr Reddys Laboratories Ltd is 18.67. This ratio indicates that investors are willing to pay 18.67 times the earnings per share for each share of Dr Reddys Laboratories Ltd.

What is the PE Ratio Growth of Dr Reddys Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Dr Reddys Laboratories Ltd grew by 9.3% whereas, the EPS ratio grew by -9.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*